Job DetailsPost Name: : Pharmacist
No. of Post: 02 Posts
Salary(in Rs.):Salary will be offered: Rs. 14000-27000/- Per month
Eligibility: 12th with 2 Year Diploma in Pharmacy. passed
Location:: Maharashtra jobs
Last Date: 24-Nov-2015
Age Limit: candidates should have to ACTREC As per Rules. Age relaxation as per government rule.
Qualification/Educational Criteria : Candidate should have passed Higher Secondary School with 2 Year Diploma in Pharmacy.
Application Fee : No Fee Requirment
Mode of Selection: Selection will be based on Interview and attended at Board Rooom, Paymaster Shodhika, TMC-ACTREC, Sec-22, Khargar, Navi Mumbai-610210..
How To ApplyInterested Candidates may attend walk in interview along with recent CV, original & Attested Photocopies of certificates on 24.11.2015.
AboutAdvanced Centre For Treatment, Research And Education In CancerThe Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer. TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India. It is registered under the Societies Registration Act (1860) and the Bombay Public Trust Act (1950). Its Governing Council is headed by the Chairman, Atomic Energy Commission, Government of India.
ACTREC comprises of 2 arms – one for basic research and another for clinical research. The basic research building was inaugurated in March 2002 at the new site of ACTREC in Kharghar, Navi Mumbai. In August 2002, the Cancer Research Institute (CRI) shifted in toto from its Parel campus in Mumbai to serve as the basic research arm of ACTREC. The clinical research arm of ACTREC comprising of the Clinical Research Centre (CRC) became functional from March 2005. ACTREC also has a 100-bed hospital fully equipped with state-of-the-art diagnostic and therapeutic facilities. Research investigations at CRI currently focus on molecular mechanisms responsible for causation of major human cancers relevant to India. It is envisaged that in the future, ACTREC will play a greater role in drug development and emerging therapies for treatment and prevention of cancer.